久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Alfasigma acquires the European license for bentracimab from PhaseBio prnasia
    June 22, 2021
    Alfasigma has entered into an exclusive licensing agreement with PhaseBio Pharmaceuticals, Inc., for the commercialization of bentracimab in 49 countries across Europe and other key markets.
  • PhaseBio and BioVectra Enter into Supply Agreement contractpharma
    March 12, 2021
    ?PhaseBio Pharmaceuticals, a clinical-stage biotech focused on the development and commercialization of novel therapies for cardiopulmonary diseases, and BioVectra, a global contract development and manufacturing organization (CDMO), have entered a ...
  • PhaseBio Announces Acquisition of Novel Oral Aldosterone Synthase Inhibitor americanpharmaceuticalreview
    January 17, 2020
    PhaseBio Pharmaceuticals has signed an agreement with Viamet Pharmaceuticals and its wholly-owned subsidiary, Selenity Pharmaceuticals, to acquire all of the assets and intellectual property rights related to certain novel aldosterone synthase inhibitors
  • PhaseBio Announces Completion of Phase 2a Trial of PB2452 americanpharmaceuticalreview
    September 26, 2019
    PhaseBio Pharmaceuticals announced the completion of its Phase 2a clinical trial of PB2452. Full data from the trial are planned to be presented at an upcoming medical congress.
PharmaSources Customer Service